Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.170 | Biomarker | disease | BEFREE | This case highlights the need to include BCR/ABL1 fusion testing to accurately diagnose pediatric patients presenting with isolated thrombocytosis. | 29187020 | 2019 | ||||
|
0.170 | GeneticVariation | disease | BEFREE | In agreement with published data, our results showed association of the BCR-ABL1 transcript e14a2 with thrombocytosis and the BCR-ABL1 transcript e13a2 with higher leukocytosis in patients with chronic myeloid leukemia. | 28437552 | 2017 | ||||
|
0.170 | GeneticVariation | disease | BEFREE | This long-sought common mutation in BCR/ABL1-negative MPD raises many provocative biological and clinical questions, and demands re-evaluation of prevailing diagnostic algorithms for erythrocytosis and thrombocytosis. | 16321848 | 2006 | ||||
|
0.170 | GeneticVariation | disease | BEFREE | There is controversy over the proper classification of thrombocytosis associated with the pathological BCR-ABL gene rearrangement; such cases are not clearly distinguishable from chronic myelogenous leukemia (CML) and should be provisionally classified as CML. | 12187022 | 2002 | ||||
|
0.170 | GeneticVariation | disease | BEFREE | A novel BCR-ABL rearrangement in a Philadelphia chromosome-positive chronic myelogenous leukaemia variant with thrombocythaemia. | 9519786 | 1998 | ||||
|
0.170 | GeneticVariation | disease | BEFREE | The c3-a2 type of BCR/ABL junction seems to be associated with elevated platelet count and thus could form a novel clinical entity different from typical CML. | 8759898 | 1996 | ||||
|
0.170 | GeneticVariation | disease | BEFREE | Among 84 consecutive patients with chronic phase Ph-positive chronic myeloid leukemia (CML) who were investigated for the hybrid BCR/ABL mRNA, in six cases (7%) the disease mimicked essential thrombocythemia (ET) at presentation, because of marked thrombocytosis (platelet counts ranging from 1003 x 10(9)/l to 2800 x 10(9)/l) and moderate leukocytosis (WBC counts from 10 x 10(9)/l to 19 x 10(9)/l). | 8684009 | 1996 | ||||
|
0.170 | Biomarker | disease | HPO |